Resolve Biosciences, the pioneer in Molecular Cartography™, today announced initial results from several prominent early access collaborations with leading laboratories across Europe. Teams of scientists are...
Read More »Long read RNA sequencing reveals subgenomic RNAs as molecular indicators of asymptomatic SARS-CoV-2 infection
In coronaviridae such as SARS-CoV-2, subgenomic RNAs (sgRNA) are replicative intermediates, therefore, their abundance and structures could infer viral replication activity and severity of host infection.
Read More »Viral sequencing can reveal how SARS-CoV-2 spreads and evolves
The emergence of SARS-CoV-2 virus variants that are adding twists in the battle against COVID-19 highlight the need for better genomic monitoring of the virus, says Katia Koelle, associate professor of biology at Emory University. “Improved genomic surveillance of SARS-CoV-2 across ...
Read More »Findings may help close door on COVID-19
Researchers at Vanderbilt University Medical Center (VUMC) and the University of Texas Medical Branch (UTMB) at Galveston have discovered what may be the Achilles’ heel of the coronavirus, a finding that may help close the door on COVID-19 and possibly ...
Read More »RNA sequencing of wastewater useful for control of SARS-CoV-2
Viral genome sequencing of wastewater can detect new SARS-CoV-2 variants before they are detected by local clinical sequencing, according to a new study reported in mBio, an open-access journal of...
Read More »Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in the lungs
Detailed knowledge about the dynamics of SARS-CoV-2 infection is important for uncovering the viral and host factors that contribute to COVID-19 pathogenesis. Old-World nonhuman primates recapitulate mild to moderate cases of COVID-19, thereby...
Read More »Twist Bioscience to offer synthetic RNA control for UK variant strain of SARS-CoV-2
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced plans to offer a new synthetic RNA control that includes the new variant of SARS-CoV-2...
Read More »RNA sequencing provides insights into why every SARS-CoV-2 infection is different
Pandurangan Vijayanand from the La Jolla Institute for Immunology , who led this study with long-time collaborator Dr Christian Ottensmeier, explained...
Read More »Currently available platforms and methodological approaches for the sequencing of SARS-CoV-2 genomes
Various next generation sequencing (NGS) based strategies have been successfully used in the recent past for tracing origins and understanding the evolution of infectious agents, investigating the spread and...
Read More »Guidelines for accurate amplicon-based sequencing of SARS-CoV-2
SARS-CoV-2 genotyping has been instrumental to monitor virus evolution and transmission during the pandemic. The reliability of the information extracted from the genotyping efforts depends on a number...
Read More »